135 related articles for article (PubMed ID: 11182752)
1. Contrasting effects of nitric oxide on food intake and GH secretion stimulated by a GH-releasing peptide.
Rigamonti AE; Cella SG; Cavallera GM; Deghenghi R; Locatelli V; Pitsikas N; Müller EE
Eur J Endocrinol; 2001 Feb; 144(2):155-62. PubMed ID: 11182752
[TBL] [Abstract][Full Text] [Related]
2. Involvement of endogneous nitric oxide in the control of pituitary responsiveness to different elicitors of growth hormone release in prepubertal rats.
Tena-Sempere M; Pinilla L; González D; Aguilar E
Neuroendocrinology; 1996 Aug; 64(2):146-52. PubMed ID: 8857609
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
Rigamonti AE; Cavallera G; Bonomo S; Deghenghi R; Locatelli V; Cella SG; Müller EE
Eur J Endocrinol; 2001 Nov; 145(5):635-44. PubMed ID: 11720883
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs.
Rigamonti AE; Cella SG; Marazzi N; Müller EE
Metabolism; 1999 Feb; 48(2):176-82. PubMed ID: 10024078
[TBL] [Abstract][Full Text] [Related]
5. Involvement of nitric oxide in the regulation of growth hormone secretion in dogs.
Valverde I; Peñalva A; Ghigo E; Casanueva FF; Dieguez C
Neuroendocrinology; 2001 Oct; 74(4):213-9. PubMed ID: 11598377
[TBL] [Abstract][Full Text] [Related]
6. Effects of systemic blockade of nitric oxide synthases on pulsatile LH, prolactin, and GH secretion in adult male rats.
Pinilla L; González LC; Tena-Sempere M; Bellido C; Aguilar E
Horm Res; 2001; 55(5):229-35. PubMed ID: 11740144
[TBL] [Abstract][Full Text] [Related]
7. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
Thomas GB; Fairhall KM; Robinson IC
Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
[TBL] [Abstract][Full Text] [Related]
8. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
Rigamonti AE; Bonomo SM; Cella SG; Müller EE
J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures.
Vankelecom H; Matthys P; Denef C
Mol Cell Endocrinol; 1997 May; 129(2):157-67. PubMed ID: 9202399
[TBL] [Abstract][Full Text] [Related]
10. History to the discovery of ghrelin.
Bowers CY
Methods Enzymol; 2012; 514():3-32. PubMed ID: 22975043
[TBL] [Abstract][Full Text] [Related]
11. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.
Panagiotidis G; Akesson B; Rydell EL; Lundquist I
Br J Pharmacol; 1995 Jan; 114(2):289-96. PubMed ID: 7533613
[TBL] [Abstract][Full Text] [Related]
12. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
13. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
Giustina A; Bonfanti C; Licini M; Ragni G; Stefana B
Regul Pept; 1997 May; 70(1):49-54. PubMed ID: 9250581
[TBL] [Abstract][Full Text] [Related]
14. Modulation of opioid-induced feeding behavior by endogenous nitric oxide in neonatal layer-type chicks.
Alimohammadi S; Zendehdel M; Babapour V
Vet Res Commun; 2015 Jun; 39(2):105-13. PubMed ID: 25677536
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-releasing peptides: clinical and basic aspects.
Argente J; García-Segura LM; Pozo J; Chowen JA
Horm Res; 1996; 46(4-5):155-9. PubMed ID: 8950613
[TBL] [Abstract][Full Text] [Related]
16. The role of nitric oxide in the control of basal and LHRH-stimulated LH secretion.
Pinilla L; Tena-Sempere M; Gonzalez D; Aguilar E
J Endocrinol Invest; 1999 May; 22(5):340-8. PubMed ID: 10401707
[TBL] [Abstract][Full Text] [Related]
17. Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: a biochemical and immunohistochemical approach.
Oztürk H; Yağmur Y; Buyukbayram H; Dokucu AI; Gurel A
Eur Surg Res; 2002; 34(4):285-90. PubMed ID: 12145554
[TBL] [Abstract][Full Text] [Related]
18. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
Bugajski J; Borycz J; Gadek-Michalska A; Głód R
J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
[TBL] [Abstract][Full Text] [Related]
20. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Gianotti L; Broglio F; Benso A; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
